I was happy to report that Elekta has reached halftime in our ACCESS 2025 strategy – Gustaf Salford
At today’s Capital Markets Day, I was happy to report that Elekta has reached halftime in our ACCESS 2025 strategy, showing growth under challenging market conditions, and we now look confidently ahead to the second half, where we’ll leverage our investments in innovation, continue to drive growth and expand our margins.
It was incredible to hear from Dr. Alison Tree how Elekta Unity is transforming treatment possibilities – giving true meaning to how we build hope. As the demand for cancer care rises, I believe that technology has the potential to transform cancer care. One such solution is our recently launched Elekta ONE software suite, a game-changer that will allow for more personalization with less effort.
We are now entering into the second half with good momentum, where we will focus on value creation. Value for our customers, value for the patients they serve and, of course, value for our shareholders. Thank you to those who joined us today, and to the team who made it happen!
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023